XOMA - 31 Year Stock Price History | XOMA

Historical daily share price chart and data for XOMA since 1989 adjusted for splits. The latest closing stock price for XOMA as of March 27, 2020 is 19.00.
  • The all-time high XOMA stock closing price was 9595.20 on March 05, 1991.
  • The XOMA 52-week high stock price is 28.85, which is 51.8% above the current share price.
  • The XOMA 52-week low stock price is 11.58, which is 39.1% below the current share price.
  • The average XOMA stock price for the last 52 weeks is 19.59.
XOMA Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 23.1822 27.6800 28.7100 15.1100 19.0000 -30.40%
2019 17.3011 13.2700 28.6600 11.8300 27.3000 115.81%
2018 21.2280 35.9200 35.9200 11.2700 12.6500 -64.47%
2017 12.5470 4.9700 36.7900 4.0300 35.6000 743.60%
2016 12.4726 26.8000 26.8000 4.2200 4.2200 -84.14%
2015 50.2669 71.0000 94.4000 14.4120 26.6000 -62.95%
2014 100.2528 138.4000 188.8000 68.6000 71.8000 -46.66%
2013 81.3167 51.8000 146.0000 50.2000 134.6000 180.42%
2012 53.9870 25.0000 79.0000 24.8000 48.0000 108.70%
2011 57.1240 106.0000 146.1000 22.0000 23.0000 -77.58%
2010 118.3450 209.8651 238.0810 45.6000 102.6000 -51.03%
2009 218.7597 200.8996 353.8231 113.9430 209.5352 12.71%
2008 601.4329 959.5202 959.5202 179.9100 185.9070 -81.71%
2007 933.1275 647.6762 1280.3598 602.6987 1016.4918 54.09%
2006 557.6432 500.7496 731.6342 476.7616 659.6702 37.50%
2005 481.9745 767.6162 767.6162 296.8516 479.7601 -38.22%
2004 1180.0909 2008.9955 2290.8546 587.7061 776.6117 -60.76%
2003 1811.7197 1202.3988 2944.5277 875.5622 1979.0105 56.03%
2002 1762.7817 2800.5997 3523.2384 929.2354 1268.3658 -57.06%
2001 3003.2173 2623.6882 5115.4423 1668.0660 2953.5232 1.03%
2000 2421.7213 890.2549 4536.7316 843.4783 2923.5382 225.00%
1999 1224.6198 1011.9940 2352.0240 618.5907 899.5502 -5.90%
1998 1216.8404 1705.5472 1836.5817 590.4048 955.9220 -42.69%
1997 1791.4643 1508.5457 2417.6912 1180.8096 1668.0660 8.44%
1996 1526.9343 1199.4003 2398.8006 937.0315 1538.2309 46.57%
1995 733.9937 815.2924 1180.8096 393.7031 1049.4753 30.21%
1994 1065.6691 1649.1754 1799.1004 674.6627 805.9970 -48.80%
1993 2021.4422 2998.5007 2998.5007 1499.2504 1574.2129 -45.45%
1992 4557.9159 6110.9445 7346.3268 2698.6507 2886.0570 -54.17%
1991 6760.4103 5997.0015 9595.2024 4272.8636 6296.8516 2.44%
1990 6053.3330 7085.4573 7796.1019 4647.6762 6146.9265 -5.75%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.190B $0.018B
XOMA Corporation is a biopharmaceutical company engaged in the discovery, development, and manufacturing of therapeutic antibodies to treat autoimmune, infectious, inflammatory, and oncological diseases. The company's flagship product is gevokizumab, a humanized antibody to interleukin-1? with potential for the treatment of the inflammatory cause of multiple diseases. XOMA Corporation, formally known as XOMA Ltd., is headquartered in Berkeley, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.071B 13.38
Gilead Sciences (GILD) United States $92.991B 12.03
CSL (CSLLY) Australia $85.089B 0.00
Vertex Pharmaceuticals (VRTX) United States $58.203B 52.82
Biogen (BIIB) United States $53.079B 9.06
Regeneron Pharmaceuticals (REGN) United States $49.761B 21.08
Illumina (ILMN) United States $40.340B 41.71
Seattle Genetics (SGEN) United States $20.006B 0.00
Alexion Pharmaceuticals (ALXN) United States $19.071B 8.87
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.120B 0.00
Incyte (INCY) United States $15.835B 33.98
BioMarin Pharmaceutical (BMRN) United States $14.869B 635.69
BioNTech SE (BNTX) Germany $12.444B 0.00
Genmab (GNMSF) Denmark $12.338B 39.68
Galapagos (GLPG) Belgium $12.125B 26.48
Alnylam Pharmaceuticals (ALNY) United States $12.122B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.935B 46.43
QIAGEN (QGEN) Netherlands $9.295B 28.34
Moderna (MRNA) United States $9.192B 0.00
Exact Sciences (EXAS) United States $9.010B 0.00
BeiGene (BGNE) Cayman Islands $8.226B 0.00
Sarepta Therapeutics (SRPT) United States $7.701B 0.00
Bio-Techne Corp (TECH) United States $7.146B 48.90
Guardant Health (GH) United States $6.713B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.139B 0.00
Ascendis Pharma (ASND) Denmark $5.402B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.400B 14.27
Exelixis (EXEL) United States $5.277B 16.94
ARGENX SE-ADR (ARGX) Netherlands $5.056B 0.00
Reata Pharmaceuticals (RETA) United States $4.948B 0.00
Amarin (AMRN) Ireland $4.894B 0.00
Repligen (RGEN) United States $4.761B 87.06
Acceleron Pharma (XLRN) United States $4.375B 0.00
China Biologic Products (CBPO) China $4.316B 25.62
MorphoSys AG (MOR) Germany $3.544B 0.00
Vir Biotechnology (VIR) United States $3.510B 0.00
Mirati Therapeutics (MRTX) United States $3.497B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.320B 0.00
Blueprint Medicines (BPMC) United States $3.308B 0.00
Adaptive Biotechnologies (ADPT) United States $3.307B 0.00
Global Blood Therapeutics (GBT) United States $3.163B 0.00
Zai Lab (ZLAB) China $3.056B 0.00
Emergent Biosolutions (EBS) United States $2.982B 20.70
NeoGenomics (NEO) United States $2.857B 123.86
Immunomedics (IMMU) United States $2.830B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.677B 45.35
Genmab (GMAB) Denmark $2.607B 10.23
Bluebird Bio (BLUE) United States $2.590B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.576B 0.00
Halozyme Therapeutics (HALO) United States $2.473B 0.00
MyoKardia (MYOK) United States $2.472B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.468B 0.00
Amicus Therapeutics (FOLD) United States $2.428B 0.00
Alkermes (ALKS) Ireland $2.271B 179.88
Intercept Pharmaceuticals (ICPT) United States $2.224B 0.00
RA PHARMCTL INC (RARX) United States $2.223B 0.00
Arena Pharmaceuticals (ARNA) United States $2.161B 5.63
Denali Therapeutics (DNLI) United States $2.034B 0.00
UniQure (QURE) Netherlands $1.989B 0.00
Alector (ALEC) United States $1.943B 0.00
Viela Bio (VIE) United States $1.928B 0.00
Eidos Therapeutics (EIDX) United States $1.862B 0.00
Principia Biopharma (PRNB) United States $1.838B 0.00
Epizyme (EPZM) United States $1.785B 0.00
Fate Therapeutics (FATE) United States $1.770B 0.00
Insmed (INSM) United States $1.661B 0.00
Arvinas (ARVN) United States $1.612B 0.00
Zymeworks (ZYME) Canada $1.491B 0.00
Akcea Therapeutics (AKCA) United States $1.460B 31.39
Dicerna Pharmaceuticals (DRNA) United States $1.350B 0.00
REGENXBIO (RGNX) United States $1.209B 0.00
Ligand Pharmaceuticals (LGND) United States $1.204B 37.40
Coherus BioSciences (CHRS) United States $1.186B 14.11
Editas Medicine (EDIT) United States $1.152B 0.00
Myriad Genetics (MYGN) United States $1.109B 19.58
Twist Bioscience (TWST) United States $1.072B 0.00
Zealand Pharma (ZEAL) Denmark $1.044B 0.00
Inovio Pharmaceuticals (INO) United States $1.042B 0.00
NextCure (NXTC) United States $1.029B 0.00
PHARMA MAR SA (PHMMF) Spain $0.985B 0.00
Adverum Biotechnologies (ADVM) United States $0.963B 0.00
NGM Biopharmaceuticals (NGM) United States $0.949B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Revance Therapeutics (RVNC) United States $0.867B 0.00
Intra-Cellular Therapies (ITCI) United States $0.861B 0.00
Sangamo Therapeutics (SGMO) United States $0.774B 0.00
Athenex (ATNX) United States $0.706B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.698B 0.00
Cytokineticsorporated (CYTK) United States $0.680B 0.00
Frequency Therapeutics (FREQ) United States $0.675B 0.00
Pharming Group (PHGUF) Netherlands $0.670B 0.00
Novavax (NVAX) United States $0.656B 0.00
Intellia Therapeutics (NTLA) United States $0.651B 0.00
Kadmon Holdings (KDMN) United States $0.649B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.625B 0.00
Cara Therapeutics (CARA) United States $0.623B 0.00
Codexis (CDXS) United States $0.618B 0.00
Retrophin (RTRX) United States $0.613B 0.00
Intrexon (PGEN) United States $0.582B 0.00
Arcus Biosciences (RCUS) United States $0.577B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.575B 0.00
GENFIT S.A (GNFT) France $0.550B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.537B 0.00
Bellus Health (BLU) Canada $0.524B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.502B 4.41
ANI Pharmaceuticals (ANIP) United States $0.492B 8.88
Compugen (CGEN) Israel $0.491B 0.00
MeiraGTx Holdings (MGTX) United States $0.485B 0.00
Castle Biosciences (CSTL) United States $0.483B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Heska (HSKA) United States $0.457B 0.00
Vericel (VCEL) United States $0.451B 66.93
Scholar Rock Holding (SRRK) United States $0.449B 0.00
AC Immune SA (ACIU) Switzerland $0.449B 10.38
Cel-Sci (CVM) United States $0.444B 0.00
DBV Technologies S.A (DBVT) France $0.437B 0.00
Mesoblast (MESO) Australia $0.436B 0.00
MiMedx (MDXG) United States $0.415B 0.00
Anika Therapeutics (ANIK) United States $0.413B 14.22
Morphic Holding (MORF) United States $0.411B 0.00
Verastem (VSTM) United States $0.406B 0.00
Prothena (PRTA) Ireland $0.404B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.400B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.400B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.398B 0.00
AnaptysBio (ANAB) United States $0.397B 0.00
Clovis Oncology (CLVS) United States $0.397B 0.00
Agenus (AGEN) United States $0.394B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.379B 0.00
Cue Biopharma (CUE) United States $0.378B 0.00
PDL BioPharma (PDLI) United States $0.373B 11.19
Adaptimmune Therapeutics (ADAP) United Kingdom $0.372B 0.00
Merus (MRUS) Netherlands $0.372B 0.00
Cellectis S.A (CLLS) France $0.370B 0.00
UROGEN PHARMA (URGN) United States $0.368B 0.00
Puma Biotechnology (PBYI) United States $0.357B 0.00
WAVE Life Sciences (WVE) Singapore $0.349B 0.00
NantKwest (NK) United States $0.342B 0.00
Sorrento Therapeutics (SRNE) United States $0.339B 0.00
BioDelivery Sciences (BDSI) United States $0.338B 39.00
Pfenex (PFNX) United States $0.332B 485.50
Athersys (ATHX) United States $0.315B 0.00
Precision BioSciences (DTIL) United States $0.310B 0.00
Cellular Biomedicine (CBMG) United States $0.310B 0.00
Dynavax Technologies (DVAX) United States $0.309B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.302B 0.00
CytomX Therapeutics (CTMX) United States $0.293B 0.00
Mersana Therapeutics (MRSN) United States $0.291B 0.00
Kala Pharmaceuticals (KALA) United States $0.283B 0.00
Avid Bioservices (CDMO) United States $0.280B 0.00
Albireo Pharma (ALBO) United States $0.278B 0.00
ADMA Biologics Inc (ADMA) United States $0.269B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.257B 0.00
Seres Therapeutics (MCRB) United States $0.249B 0.00
Kamada (KMDA) Israel $0.247B 10.26
Syros Pharmaceuticals (SYRS) United States $0.246B 0.00
Sutro Biopharma (STRO) United States $0.245B 0.00
MannKind (MNKD) United States $0.234B 0.00
Alcobra (ARCT) United States $0.231B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.226B 0.00
Gritstone Oncology (GRTS) United States $0.226B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.225B 0.00
Geron (GERN) United States $0.224B 0.00
Aduro Biotech (ADRO) United States $0.221B 0.00
Stemline Therapeutics (STML) United States $0.214B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.209B 1.88
OSMOTICA PHARM (OSMT) United States $0.196B 0.00
HOOKIPA Pharma (HOOK) United States $0.192B 0.00
Selecta Biosciences (SELB) United States $0.185B 0.00
VBI Vaccines (VBIV) United States $0.182B 0.00
IVERIC Bio (ISEE) United States $0.180B 0.00
ChromaDex (CDXC) United States $0.179B 0.00
Kindred Biosciences (KIN) United States $0.177B 0.00
Abeona Therapeutics (ABEO) United States $0.176B 0.00
Protagonist Therapeutics (PTGX) United States $0.173B 0.00
Spero Therapeutics (SPRO) United States $0.164B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
Arbutus Biopharma (ABUS) Canada $0.156B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.151B 0.00
Cerecor (CERC) United States $0.150B 0.00
Prometic Life Sciences (LMNL) Canada $0.150B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.150B 0.00
Starpharma Holdings (SPHRY) Australia $0.149B 0.00
VolitionRX (VNRX) United States $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.145B 0.00
Liquidia Technologies (LQDA) United States $0.138B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.135B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.135B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.134B 5.27
Fortress Biotech (FBIO) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Windtree Therapeutics (WINT) United States $0.134B 0.00
VTv Therapeutics (VTVT) United States $0.132B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.124B 0.00
Theratechnologies (THTX) Canada $0.124B 0.00
Dyadic (DYAI) United States $0.122B 0.00
Antibe Therapeutics (ATBPF) Canada $0.120B 0.00
Affimed (AFMD) Germany $0.120B 0.00
Exicure (XCUR) United States $0.119B 0.00
Enzo Biochem (ENZ) United States $0.118B 0.00
Strongbridge Biopharma (SBBP) United States $0.110B 0.00
Palatin Technologies (PTN) United States $0.108B 2.94
Celyad SA (CYAD) Belgium $0.106B 0.00
AIT Therapeutics (XAIR) United States $0.104B 0.00
CorMedix Inc (CRMD) United States $0.100B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
Northwest Biotherapeutics (NWBO) United States $0.099B 0.00
OvaScience (MLND) United States $0.099B 0.00
Checkpoint Therapeutics (CKPT) United States $0.097B 0.00
Aptinyx (APTX) United States $0.097B 0.00
Five Prime Therapeutics (FPRX) United States $0.093B 0.00
PHASEBIO PHARMA (PHAS) United States $0.092B 0.00
IBio (IBIO) United States $0.091B 0.00
TELA Bio (TELA) United States $0.091B 0.00
Cyclerion Therapeutics (CYCN) United States $0.090B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
ARAVIVE, INC (ARAV) United States $0.078B 0.00
Happiness Biotech Group (HAPP) China $0.077B 0.00
Menlo Therapeutics (MNLO) United States $0.077B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.072B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.069B 0.00
SESEN BIO, INC (SESN) United States $0.068B 0.00
Aytu Bioscience (AYTU) United States $0.067B 0.00
Adocia (ADOCY) France $0.066B 0.00
Applied Genetic Technologies (AGTC) United States $0.066B 0.00
Proteostasis Therapeutics (PTI) United States $0.065B 0.00
Synlogic (SYBX) United States $0.065B 0.00
Orgenesis (ORGS) United States $0.062B 3.66
Eton Pharmaceuticals (ETON) United States $0.060B 0.00
Trevena (TRVN) United States $0.059B 0.00
AquaBounty Technologies (AQB) United States $0.059B 0.00
Pluristem Therapeutics (PSTI) Israel $0.058B 0.00
Catalyst Biosciences (CBIO) United States $0.057B 0.00
Emmaus Life Sciences (EMMA) United States $0.056B 0.00
Acorda Therapeutics (ACOR) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.049B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.049B 0.00
Idera Pharmaceuticals (IDRA) United States $0.042B 0.00
Soligenix (SNGX) United States $0.038B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.037B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.036B 0.00
Advaxis (ADXS) United States $0.036B 0.00
Lumos Pharma (LUMO) United States $0.035B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.034B 0.00
TOCAGEN INC (TOCA) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
CollPlant Holdings (CLGN) Israel $0.034B 0.00
Prima BioMed (IMMP) Australia $0.030B 0.00
Signal Genetics (MGEN) United States $0.030B 0.00
Celldex Therapeutics (CLDX) United States $0.029B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.029B 0.00
Evogene (EVGN) Israel $0.028B 0.00
Curis (CRIS) United States $0.027B 0.00
Entera Bio (ENTX) Israel $0.027B 0.00
VistaGen Therapeutics (VTGN) United States $0.024B 0.00
Alimera Sciences (ALIM) United States $0.023B 0.00
Novogen (KZIA) Australia $0.022B 0.00
Pulmatrix (PULM) United States $0.021B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Celsion (CLSN) United States $0.021B 0.00
Stellar Biotechnologies (EDSA) Canada $0.019B 0.00
Apricus Biosciences (SEEL) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
BioCardia (BCDA) United States $0.019B 0.00
Oncobiologics (OTLK) United States $0.018B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.015B 0.00
Aptevo Therapeutics (APVO) United States $0.012B 0.00
AEterna Zentaris (AEZS) United States $0.012B 0.00
ATyr Pharma (LIFE) United States $0.012B 0.00
TrovaGene (TROV) United States $0.010B 0.00
VIVUS (VVUS) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00